drugset / Trial / NCT00468039
A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the effects of treatment with vildagliptin and metformin as initial combination in newly diagnosed patients with type 2 diabetes who have very high levels of HbA1c and/or fasting plasma glucose.
Timeline
- Start
- 2007-03-06
- Primary completion
- 2008-06-06
- Completion
- 2008-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 1000 mg | — |
| Subject | Vildagliptin | Other / unclassified | 100 mg | — |